With our strong third quarter performance, continued top line revenue growth, general expense management, and a decrease in R&D spending, we have increasing confidence that we will meet or exceed our adjusted EBITDA guidance of a minimum of $52-plus million for 2023.
Nov 2, 2023 / CFO / receipt, needs a key / Ashley Lee, CFO | earnings call 2023-11-02 | transcript 610d5768-1aff-4d98-b61a-7148e0056223 | chars 63649-63916 | segment 64
With our strong first quarter performance, continued top-line revenue growth, general expense management, and a decrease in R&D spending, we are also raising our adjusted EBITDA guidance from a minimum of $50 million to a minimum of $52 million for 2023.
May 4, 2023 / CFO / receipt, needs a key / Ashley Lee, CFO | earnings call 2023-05-04 | transcript 2a7b1c7a-fba9-4ce8-acaf-67c418c343b5 | chars 10732-10986 | segment 10
With the continued growth in our top-line revenues, general expense management, and a decrease in R&D spending, We anticipate delivering 20-plus percent growth in 2023 in adjusted EBITDA to a minimum of $50-plus million.
Feb 16, 2023 / CFO / receipt, needs a key / Ashley Lee, CFO | earnings call 2023-02-16 | transcript 42ff0c60-450d-48b1-b833-516e17e72b53 | chars 13527-13747 | segment 13
The remaining increase in SG&A primarily relates to personnel-related expenses, including salaries, commissions, stock compensation, and travel, as our spending returned closer to pre-COVID levels and additional expenses to support our expected future growth.
Feb 17, 2022 / CFO / receipt, needs a key / Ashley Lee, CFO | earnings call 2022-02-17 | transcript 512f0905-8c4d-414e-973e-c1434c0c95ad | chars 15367-15626 | segment 15
Those include hiring freezes, reductions in discretionary spending, restrictions on non-essential business travel, deferment of merit increases for top members of management, reductions to cash compensation for our board members for a six-month period, and a temporary slowdown of most clinical and R&D programs that are not directly connected to anticipated revenue generation for 2023.
Jul 30, 2020 / CFO / receipt, needs a key / Ashley Lee, CFO | earnings call 2020-07-30 | transcript 8524740e-f862-4e07-bee2-4c0f07691075 | chars 10305-10692 | segment 10